Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
320 participants
OBSERVATIONAL
2008-10-31
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Schizophrenic patients with a acute episode treated in outpatients clinics
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed of Schizophrenia of Schizoaffective Disorder based on DSM-IV-TR
* With an acute episode or worsening of clinical status. Defined as change in clinical status that need a significant change in therapeutic plan.
* Able to understand and comply with requirements of the study
Exclusion Criteria
* Unstable somatic disease, that is not receiving adequate treatment, based on investigator opinion.
* To have been recruited in a clinical trial in the last 4 weeks
* To have planned the inclusion in a clinical trial during the follow-up of this study
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Vitoria-Gasteiz, Alava, Spain
Research Site
Almansa, Albacete, Spain
Research Site
Alcoy, Alicante, Spain
Research Site
Alicante, Alicante, Spain
Research Site
Benidorm, Alicante, Spain
Research Site
El Ejido, Almeria, Spain
Research Site
Roquetas de Mar, Almeria, Spain
Research Site
Zafra, Badajoz, Spain
Research Site
Manacor, Balearic Islands, Spain
Research Site
Palma de Mallorca, Balearic Islands, Spain
Research Site
Barcelona, Barcelona, Spain
Research Site
El Hospitalet de Llobregat, Barcelona, Spain
Research Site
Gavà, Barcelona, Spain
Research Site
Manresa, Barcelona, Spain
Research Site
Mataró, Barcelona, Spain
Research Site
Sabadell, Barcelona, Spain
Research Site
Sant Feliu de Llobregat, Barcelona, Spain
Research Site
Santa Coloma de Gramanet, Barcelona, Spain
Research Site
Terrassa, Barcelona, Spain
Research Site
Aranda de Duero, Burgos, Spain
Research Site
Cáceres, Caceres, Spain
Research Site
Maliaño, Cantabria, Spain
Research Site
Vinaròs, Castellon, Spain
Research Site
Donostia / San Sebastian, Guipuzcoa, Spain
Research Site
Errenteria, Guipuzcoa, Spain
Research Site
Alcalá la Real, Jaen, Spain
Research Site
Linares, Jaen, Spain
Research Site
Logroño, La Rioja, Spain
Research Site
Banaderos, Las Palmas, Spain
Research Site
Montforte, Lugo, Spain
Research Site
Alcalá de Henares, Madrid, Spain
Research Site
Colmenar Viejo, Madrid, Spain
Research Site
Fuenlabrada, Madrid, Spain
Research Site
Getafe, Madrid, Spain
Research Site
Leganés, Madrid, Spain
Research Site
Madrid, Madrid, Spain
Research Site
Málaga, Malaga, Spain
Research Site
Vélez-Málaga, Malaga, Spain
Research Site
Caravaca de La Cruz, Murcia, Spain
Research Site
Cartagena, Murcia, Spain
Research Site
Elizondo, Navarre, Spain
Research Site
Vigo, Pontevedra, Spain
Research Site
Arriondas, Principality of Asturias, Spain
Research Site
Avilés, Principality of Asturias, Spain
Research Site
Gijón, Principality of Asturias, Spain
Research Site
Oviedo, Principality of Asturias, Spain
Research Site
Béjar, Salamanca, Spain
Research Site
Salamanca, Salamanca, Spain
Research Site
Alcalá de Guadaira, Sevilla, Spain
Research Site
Écija, Sevilla, Spain
Research Site
Seville, Sevilla, Spain
Research Site
Soria, Soria, Spain
Research Site
El Vendrell, Tarragona, Spain
Research Site
Reus, Tarragona, Spain
Research Site
Adeje, Tenerife, Spain
Research Site
San Cristóbal de La Laguna, Tenerife, Spain
Research Site
Santa Cruz de Tenerife, Tenerife, Spain
Research Site
Toledo, Toledo, Spain
Research Site
Adaia, Valencia, Spain
Research Site
Catarroja, Valencia, Spain
Research Site
Mislata, Valencia, Spain
Research Site
Valencia, Valencia, Spain
Research Site
Valladolid, Valladolid, Spain
Research Site
Bilbao, Vizcaya, Spain
Research Site
Zaragoza, Zaragoza, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-NES-DUM-2008/2
Identifier Type: -
Identifier Source: org_study_id